Guido Franceschini
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 22, 2019
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders.
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: October 10, 2017
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation.
Journal: Scientific reports
Published: July 24, 2017
Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
Published: December 14, 2016
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.
Journal: Journal of lipid research
Published: September 30, 2016
Role of LCAT in Atherosclerosis.
Journal: Journal of atherosclerosis and thrombosis
Published: November 27, 2015
Lipoprotein X Causes Renal Disease in LCAT Deficiency.
Journal: PloS one
Published: September 25, 2015
Protective Effects of HDL Against Ischemia/Reperfusion Injury.
Journal: Frontiers in pharmacology
Published: September 21, 2015
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 22, 2015
Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.
Journal: Vascular pharmacology
Published: February 25, 2015
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.
Journal: Vascular pharmacology
Published: February 11, 2015
Last Updated: 09/26/2026